Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 38INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 13Gastrointestinal 9Breast 9Other hematologic neoplasm 7Thoracic 6Plasma cell 6Lymphoid 5Tumor-Agnostic 4Head & Neck 4Gynecologic 4CNS 4Dermatologic 2Sarcoma 1Other solid neoplasm 1Myeloid 1Classical hematology 1

Conditions

Head and Neck Neoplasms 4Stomatitis 1Recurrence 1

Interventions

pembrolizumab 166Cisplatin 112Cetuximab 76Nivolumab 52Carboplatin 51Fluorouracil 48Paclitaxel 42Docetaxel 37Gemcitabine 30Radiotherapy 28Capecitabine 19Cyclophosphamide 18durvalumab 17Injections 17lenvatinib 16atezolizumab 16cemiplimab 15spartalizumab 13fludarabine 13avelumab 12Ipilimumab 12Pemetrexed 11130-nm albumin-bound paclitaxel 11Oxaliplatin 10Gefitinib 10tremelimumab 9Drug Therapy 9tislelizumab 8epacadostat 8budigalimab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Standard of Care × Head & Neck × Clear all
NCT04963972 2022-05-10

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

Lucid Lane, Inc

Phase NA Unknown
272 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02369874 2021-02-10

EAGLE

AstraZeneca

Phase 3 Completed
736 enrolled 26 charts
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Hoffmann-La Roche

Phase 3 Terminated
94 enrolled 6 charts
Head & Neck

Head and Neck Neoplasms

NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Endo Pharmaceuticals

Phase 3 Terminated
240 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡